Literature DB >> 20159989

Formation and distribution of NNK metabolites in an isolated perfused rat lung.

Laura A Maertens1, Pramod Upadhyaya, Stephen S Hecht, Cheryl L Zimmerman.   

Abstract

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a lung-specific tobacco carcinogen. Metabolism is critical to its elimination given its lipophilic nature. Although NNK can be metabolized through detoxification pathways that safely eliminate it from the body, it can also be bioactivated, resulting in the formation of potentially carcinogenic DNA adducts. The isolated perfused rat lung (IPRL) system was used to determine the effect of NNK perfusate concentration (0.1 and 1.2 microM) on the formation and distribution of metabolites, the level of individual DNA adducts, and total covalent binding in the lung. Coadministration of the chemopreventive agent phenethyl isothiocyanate (PEITC; 20 microM) was also examined to determine its effect on NNK metabolism. NNK was readily metabolized in the IPRL system. In the 0.1 muM perfusions approximately 55% of metabolites formed were through detoxification pathways, whereas roughly 30% were the result of bioactivation pathways. An increase in NNK concentration increased the percentage of unmetabolized NNK and decreased the apparent metabolic clearance in the lung, but the metabolite profiles remained similar between concentrations. The addition of PEITC reduced the formation of oxidative metabolites and increased 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) formation and the percentage of unmetabolized NNK. PEITC also significantly decreased the formation of DNA adducts in the lung tissue. The level of O(2)-[4-(3-pyridyl)-4-oxobut-1-yl]thymidine (O(2)-POB-dThd) and O(6)-[4-(3-pyridyl)-4-oxobut-1-yl]-2'-deoxyguanosine (O(6)-POB-dGuo) decreased by 70 to 75%, and that of O(6)-methylguanine (O(6)-methyl-Gua) and 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine (7-POB-Gua) decreased by 40 to 45%. Pyridylhydroxybutyl-DNA adducts were not detected in any of the treatment groups. Thus, the IPRL system is useful in determining pulmonary metabolism and DNA adduct formation separate from other metabolizing organs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159989      PMCID: PMC2872947          DOI: 10.1124/dmd.109.031492

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  34 in total

1.  Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues.

Authors:  P Upadhyaya; S G Carmella; F P Guengerich; S S Hecht
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.

Authors:  A Atalla; E Maser
Journal:  Toxicology       Date:  1999-11-29       Impact factor: 4.221

3.  Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.

Authors:  John R Jalas; Xinxin Ding; Sharon E Murphy
Journal:  Drug Metab Dispos       Date:  2003-10       Impact factor: 3.922

4.  Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.

Authors:  Ursula Breyer-Pfaff; Hans-Jörg Martin; Michael Ernst; Edmund Maser
Journal:  Drug Metab Dispos       Date:  2004-09       Impact factor: 3.922

5.  Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.

Authors:  Elmar Richter; Johannes Engl; Susanne Friesenegger; Anthony R Tricker
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

Review 6.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer.

Authors:  Stephen S Hecht
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

7.  Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.

Authors:  S A Belinsky; C M White; J A Boucheron; F C Richardson; J A Swenberg; M Anderson
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

8.  Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats.

Authors:  D Hoffmann; A Rivenson; S Amin; S S Hecht
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

9.  Solute conductance of blood-gas barrier in hamsters exposed to hyperoxia.

Authors:  D Wangensteen; R Piper; J A Johnson; A A Sinha; D Niewoehner
Journal:  J Appl Physiol (1985)       Date:  1986-06

10.  Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and the relationship to carcinogenicity.

Authors:  T R Devereux; M W Anderson; S A Belinsky
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more
  2 in total

1.  Effects of cellular differentiation in human primary bronchial epithelial cells: Metabolism of 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone.

Authors:  Qin Qin; Qiangen Wu; Yiying Wang; Rui Xiong; Lei Guo; Xin Fu; Hans Rosenfeldt; Matthew Bryant; Xuefei Cao
Journal:  Toxicol In Vitro       Date:  2018-12-13       Impact factor: 3.500

2.  XB130 translocation to microfilamentous structures mediates NNK-induced migration of human bronchial epithelial cells.

Authors:  Qifei Wu; Jeya Nadesalingam; Serisha Moodley; Xiaohui Bai; Mingyao Liu
Journal:  Oncotarget       Date:  2015-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.